Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Number of holders
-
173
-
Total 13F shares, excl. options
-
58,378,537
-
Shares change
-
+286,713
-
Total reported value, excl. options
-
$2,626,676,199
-
Value change
-
+$33,782,408
-
Put/Call ratio
-
76%
-
Number of buys
-
95
-
Number of sells
-
80
-
Price
-
$45.00
Institutional Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q2 2019
As of 30 Jun 2019 PTC THERAPEUTICS, INC. - Common Stock (PTCT) had 222 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 58,378,537 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., FRANKLIN RESOURCES INC, PRICE T ROWE ASSOCIATES INC /MD/, RTW INVESTMENTS, LP, Point72 Asset Management, L.P., FMR LLC, STATE STREET CORP, ORBIMED ADVISORS LLC, and GREAT POINT PARTNERS LLC.
This table shows 222 institutional shareholders of the security as of 30 Jun 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.